Drug Shortage Report for DILANTIN-125 SUSPENSION

Last updated on 2022-04-01 History
Report ID 151037
Drug Identification Number 00023450
Brand name DILANTIN-125 SUSPENSION
Common or Proper name Dilantin
Company Name UPJOHN CANADA ULC
Market Status MARKETED
Active Ingredient(s) PHENYTOIN
Strength(s) 125MG
Dosage form(s) SUSPENSION
Route of administration ORAL ORAL
Packaging size Oral Suspension 250ml
ATC code N03AB
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-12-23
Actual start date 2022-01-07
Estimated end date 2022-04-01
Actual end date 2022-03-31
Shortage status Resolved
Updated date 2022-04-01
Company comments One lot with an expiry date of June/30/2022 remains available in stock
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-833-287-5646 Email / courriel: UpjohnCanadaCustomerService@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2022-04-01 English Compare
v16 2022-03-31 French Compare
v15 2022-03-31 English Compare
v14 2022-03-24 French Compare
v13 2022-03-24 English Compare
v12 2022-03-22 French Compare
v11 2022-03-22 English Compare
v10 2022-03-22 English Compare
v9 2022-03-15 French Compare
v8 2022-03-15 English Compare
v7 2022-03-07 French Compare
v6 2022-03-07 English Compare
v5 2022-01-17 French Compare
v4 2022-01-17 English Compare
v3 2021-12-24 English Compare
v2 2021-12-13 French Compare
v1 2021-12-13 English Compare

Showing 1 to 17 of 17